LENZ Therapeutics's total assets for Q4 2025 were $305.88M, an increase of 45.17% from the previous quarter. LENZ total liabilities were $21.54M for the fiscal quarter, a 28.37% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.